|1.||Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO): 1 article (11/2013)|
|2.||Jarvis, Virginia: 1 article (11/2013)|
|3.||Bowen, Joanne: 1 article (11/2013)|
|4.||Zadik, Yehuda: 1 article (11/2013)|
|5.||Barasch, Andrei: 1 article (11/2013)|
|6.||Yarom, Noam: 1 article (11/2013)|
|7.||Lalla, Rajesh V: 1 article (11/2013)|
|8.||Jensen, Siri Beier: 1 article (11/2013)|
|9.||Elad, Sharon: 1 article (11/2013)|
|10.||Ariyawardana, Anura: 1 article (11/2013)|
08/01/1997 - "These results indicate that TCDO may be helpful in palliating some of the symptoms related to oral mucositis. "
08/01/1997 - "A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis."
11/01/2013 - "The aim of this systematic review was to analyze the available literature and define clinical practice guidelines for the use of the following agents for the prevention and treatment of oral mucositis (OM): allopurinol, midline mucosa-sparing radiation blocks, payayor, pentoxifylline, timing of radiation therapy (RT) (morning versus late afternoon), pilocarpine, bethanechol, chewing gum, propantheline, and tetrachlorodecaoxide. "
08/01/1999 - "The result suggests good efficacy of TCDO in the treatment of postradiation cystitis."
01/01/2006 - "To evaluate efficacy and safety of WF10 (TCDO iv solution) therapy in patients with late hemorrhagic radiation cystitis and proctitis in a long-term follow up. "
08/01/1999 - "The objective of this study was to evaluate the efficacy of chemically-stabilized chlorite-matrix (TCDO) in patients with severe radiation cystitis. "
08/01/1999 - "The efficacy of chemically-stabilized chlorite-matrix (TCDO) in the management of late postradiation cystitis."
|3.||Radiation-Induced Leukemia (Leukemia, Radiation Induced)
08/01/1994 - "In particular, there was a highly significant prevention of radiation-induced leukemia [P (one-sided) < 0.001] by TCDO, and a significantly reduced incidence of malignant epithelial tumors [P (one-sided) < 0.05]. "
11/01/1994 - "The effect of tetrachlorodecaoxide (TCDO) treatment after total-body irradiation (TBI) with gamma-rays (single dose, about LD 50) on the development of radiation-induced leukemia was tested in rats. "
|4.||Acute Radiation Syndrome
08/01/1994 - "In conclusion, TCDO is not only a potent therapeutic agent in acute radiation syndrome, but it also significantly reduced the carcinogenic risk in rats after exposure to ionizing radiation."
08/01/1994 - "Tetrachlorodecaoxygen (TCDO) therapy of acute radiation syndrome was tested for a possible influence on the development of X-ray-induced malignancies. "
08/01/1997 - "Time to subjective improvement in oral pain was significantly shorter with TCDO (3.1 versus 3.6 days). "
08/01/1997 - "Evaluation on day 3 revealed that 77% of those receiving TCDO were free of oral pain in comparison to 46% receiving placebo (P = 0.05). "
08/01/1997 - "Post-therapy evaluation revealed no significant difference in the mean grade of oral and esophageal pain, or dysphagia between TCDO and placebo. "
|6.||Sodium Chloride (Saline Solution)
|9.||Propantheline (Propantheline Bromide)
|1.||Drug Therapy (Chemotherapy)